In This Article:
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Synchrony Financial SYF: This consumer financial services company has seen the Zacks Consensus Estimate for its current year earnings increasing 18.2% over the last 60 days.
Synchrony Financial Price and Consensus
Synchrony Financial price-consensus-chart | Synchrony Financial Quote
SouthState Corporation SSB: This bank holding company for SouthState Bank has seen the Zacks Consensus Estimate for its current year earnings increasing 7.8% over the last 60 days.
SouthState Corporation Price and Consensus
SouthState Corporation price-consensus-chart | SouthState Corporation Quote
Veracyte, Inc. VCYT: This diagnostics company has seen the Zacks Consensus Estimate for its current year earnings increasing 20.4% over the last 60 days.
Veracyte, Inc. Price and Consensus
Veracyte, Inc. price-consensus-chart | Veracyte, Inc. Quote
Day One Biopharmaceuticals, Inc. DAWN: This clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 17.1% over the last 60 days.
Day One Biopharmaceuticals, Inc. Price and Consensus
Day One Biopharmaceuticals, Inc. price-consensus-chart | Day One Biopharmaceuticals, Inc. Quote
Financial Institutions, Inc. FISI: This holding company for the Five Star Bank has seen the Zacks Consensus Estimate for its current year earnings increasing 7.5% over the last 60 days.
Financial Institutions, Inc. Price and Consensus
Financial Institutions, Inc. price-consensus-chart | Financial Institutions, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Financial Institutions, Inc. (FISI) : Free Stock Analysis Report
Synchrony Financial (SYF) : Free Stock Analysis Report
Veracyte, Inc. (VCYT) : Free Stock Analysis Report
SouthState Corporation (SSB) : Free Stock Analysis Report
Day One Biopharmaceuticals, Inc. (DAWN) : Free Stock Analysis Report